Oculis Taps Shire Veteran de Souza Lima as Chief Medical Officer

Marcia de Souza Lima has been appointed chief medical officer of eye drug developer Oculis. She most recently worked at Shire, where she was vice president and head of global medical affairs for ophthalmics. Her experience also includes positions at Regenxbio, Novartis (NYSE: [[ticker:NVS]]), Pfizer (NYSE: [[ticker:PFE]]), Bausch & Lomb, and Ancile Pharmaceuticals. Lausanne, Switzerland-based Oculis is preparing to advance OCS-01, an experimental treatment for diabetic macular edema, into late-stage clinical testing.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan